A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation
Open Access
- 15 October 2008
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 112 (8), 3036-3047
- https://doi.org/10.1182/blood-2007-10-118372
Abstract
The increased use of hematopoietic progenitor cell (HPC) transplantation has implications and consequences for transfusion services: not only in hospitals where HPC transplantations are performed, but also in hospitals that do not perform HPC transplantations but manage patients before or after transplantation. Candidates for HPC transplantation have specific and specialized transfusion requirements before, during, and after transplantation that are necessary to avert the adverse consequences of alloimmunization to human leukocyte antigens, immunohematologic consequences of ABO-mismatched transplantations, or immunosuppression. Decisions concerning blood transfusions during any of these times may compromise the outcome of an otherwise successful transplantation. Years after an HPC transplantation, and even during clinical remission, recipients may continue to be immunosuppressed and may have critically important, special transfusion requirements. Without a thorough understanding of these special requirements, provision of compatible blood components may be delayed and often urgent transfusion needs prohibit appropriate consultation with the patient's transplantation specialist. To optimize the relevance of issues and communication between clinical hematologists, transplantation physicians, and transfusion medicine physicians, the data and opinions presented in this review are organized by sequence of patient presentation, namely, before, during, and after transplantation.Keywords
This publication has 102 references indexed in Scilit:
- Peripheral Blood Grafts from Unrelated Donors Are Associated with Increased Acute and Chronic Graft-versus-Host Disease without Improved SurvivalTransplantation and Cellular Therapy, 2007
- Lack of effect of donor‐recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantationTransfusion, 2007
- Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 × 109 and 20 × 109 per LTransfusion, 2007
- Diffuse Alveolar Hemorrhage: Retrospective Review of Clinical Outcome in Allogeneic Transplant Recipients Treated With Aminocaproic AcidTransplantation and Cellular Therapy, 2006
- Lack of effect of donor–recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2006
- ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation RevisitedTransplantation and Cellular Therapy, 2005
- Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old themeBone Marrow Transplantation, 2004
- Fludarabine treatment and transfusion-associated graft-versus-host diseaseThe Lancet, 1996
- Use of minors as bone marrow donors: Current attitude and management: A survey of 56 pediatric transplantation centersThe Journal of Pediatrics, 1996
- Graft versus host disease after transfusions of non-irradiated blood cells in patients having received autologous bone marrowEuropean Journal of Cancer and Clinical Oncology, 1988